BDX Becton Dickinson Earnings and EPS analysis
- Stocks
- Healthcare
- NYSE: BDX
- Earnings
EPS in 2025 (TTM): $5.18
Last Report Period Date: Mar 31, 2025
According to the most recent financial data from March 2025, the current EPS (TTM) is $5.18. Becton Dickinson's EPS for 2024 came in at $5.88, marking an increase from $4.97 in 2023. For the quarterly period ending on Mar 31, 2025, BDX's EPS was $1.07.
BDX earnings history
Becton Dickinson had an annual EPS of $5.88, marking an increase of 18.3% from $4.97 in 2023. The quarterly EPS for the period ending Mar 31, 2025, was $1.07, marking a 42.2% decrease from the same quarter last year. BDX's TTM EPS stands at $5.18 as of March 2025. Becton Dickinson's EPS for 2023 stood at $4.97, a 16.2% decrease from 2022.
BDX EPS growth
Over the last 12 months, Becton Dickinson has registered an EPS growth of -42.2% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of -5.3% per year over the past 3 years. Over the last 5 years, the company had an average EPS growth rate of 8%. A 10-year view shows that BDX has seen an average EPS growth of -0.4% per year.
BDX Earnings Waterfall
BDX Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| TMO Thermo Fisher Scientific Inc | 25.45 | 6.8% | -5.5% | 12.4% |
| HOLX Hologic Inc | 27.5 | 81.1% | -22.8% | N/A |
| RMD Resmed Inc | 28.46 | 13.4% | 28.5% | 19.7% |
| LH Laboratory Corp Of America Holdings | 28.63 | 85.2% | -28.8% | 1.1% |
| BDX Becton Dickinson & Co | 33.97 | 18.3% | -5.3% | 8% |
| TFX Teleflex Inc | 35.71 | -80.3% | -47.6% | -31.7% |
| ISRG Intuitive Surgical Inc | 73.68 | 27.7% | 10.9% | 10.4% |
| XRAY DENTSPLY SIRONA Inc | N/A | -622.6% | N/A | N/A |
| BAX Baxter International Inc | N/A | -124.2% | N/A | N/A |
| BIO Bio-Rad Laboratories Inc | N/A | -199.5% | N/A | N/A |
| HBIO Harvard Bioscience Inc | N/A | -250% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.